News | February 25, 2022
Canada approves plant-based Covid-19 vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
This surpasses the number of approvals supported in 2020
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
Key takeaways of recent quarter & conference call highlights
In the final analysis of Phase 3 COVE study data, SPIKEVAX showed 93% efficacy, with the efficacy remaining durable through six months after the administration of the second dose
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian market
Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets
Vivimed strategy is to increase its share of Branded products in CIS Markets.
Subscribe To Our Newsletter & Stay Updated
